Lek to build US$400m biosimilars production facility in Lendava
Ljubljana, 9 March - The government and the pharmaceutical company Lek, which is part of Swiss generics group Sandoz, signed a memorandum of understanding for Lek's high-tech biosimilars plant worth US$400 million in the town of Lendava as PM Robert Golob and Economy Minister Matjaž Han met Lek and Sandoz senior executives in Ljubljana on Thursday.
Ljubljana
Economy Minister Matjaž Han (right) and Lek CEO Robert Ljoljo signing a memorandum of understanding for Lek's new investment.
Photo: Nebojša Tejić/STA
Ljubljana
Sandoz CEO Richard Saynor and PM Robert Golob speaking to the press after the signing of a memorandum of understanding for Lek's new investment.
Photo: Nebojša Tejić/STA
Ljubljana
Sandoz CEO Richard Saynor and PM Robert Golob speaking to the press after the signing of a memorandum of understanding for Lek's new investment.
Photo: Nebojša Tejić/STA
Ljubljana
A meeting at the Presidential Palace between PM Robert Golob and Economy Minister Matjaž Han, and Sandoz CEO Richard Saynor and Lek CEO and Sandoz Slovenija president Robert Ljolj.
Photo: Nebojša Tejić/STA
Ljubljana
A meeting at the Presidential Palace between PM Robert Golob and Economy Minister Matjaž Han, and Sandoz CEO Richard Saynor and Lek CEO and Sandoz Slovenija president Robert Ljolj.
Photo: Nebojša Tejić/STA
Ljubljana
A meeting at the Presidential Palace between PM Robert Golob and Economy Minister Matjaž Han, and Sandoz CEO Richard Saynor and Lek CEO and Sandoz Slovenija president Robert Ljolj.
Photo: Nebojša Tejić/STA
The rest of this news item is available to subscribers.
The news item consists of 2.242 characters (without spaces) or 420 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.